New study aims to uncover hidden superbug threat in transplant patients
NCT ID NCT07324291
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will follow 1,000 adults who have received a stem cell transplant to track a type of antibiotic-resistant bacteria called MBL-CRE. Researchers will use regular swab tests to see how often patients carry these bacteria and how often they develop infections. The goal is to better understand the risks and resistance patterns to improve future prevention and treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors predict and prevent dangerous infections in stem cell transplant patients.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly benefit participants and may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Life-Saving transplant leave hidden scars on a Child's mind?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can personalized antibiotics outsmart resistant bacteria in liver transplants?
- Could a simple drug infusion stop a dangerous virus after stem cell transplants?
- Study to reveal if younger donors boost transplant success
- Can donor t cells beat a tough virus after transplant? new trial aims to find out.